Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Radiological Investigation III: Pulmonary Angiogram and PET Scan

Radiological Investigation III: Pulmonary Angiogram and PET Scan

Radiological investigations are paramount in the diagnosis and management of various pulmonary diseases. Two essential investigations are the Pulmonary Angiogram and the Positron Emission Tomography (PET) Scan.
Pulmonary Angiogram
A Pulmonary Angiogram is an invasive procedure involving injecting a contrast medium through a catheter threaded into the pulmonary artery or the right side of the heart to visualize the pulmonary vasculature. Computed Tomography (CT) scans have mainly replaced this...

Imaging Studies II: Positron Emission Tomography and Scintigraphy

Imaging Studies II: Positron Emission Tomography and Scintigraphy

Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET

Positron Emission Tomography

Positron Emission Tomography

Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body being...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

<sup>68</sup>Ga-PSMA PET/CT in biochemically recurrent prostate cancer: association with genomic data.

European journal of nuclear medicine and molecular imaging·2026

Same author

Functional Renal Assessment via Dynamic LAFOV <sup>18</sup>F-FDG PET/CT in a Patient with Recurrent Extranodal Marginal-Zone Lymphoma.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2026

Same author

Impact of Bridging Response on Outcomes after CD19 CAR T-Cell Therapy in Large B-Cell Lymphoma.

Transplantation and cellular therapy·2026

Same author

Nonsteroidal <sup>18</sup>F-Labeled PET Tracer for Imaging Androgen Receptors.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2026

Same author

Diagnostic Value of Routine Delayed Pelvic Imaging for Patients with Biochemical Recurrence of Prostate Cancer Undergoing <sup>68</sup>Ga-PSMA PET/CT.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2026

Same author

Prostate Cancer, Part 2: PSMA and Beyond.

Journal of nuclear medicine technology·2026

Search research articles

Related Experiment Video

Updated: May 12, 2026

Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT

Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT

Published on: January 22, 2018

Reporting guidance for oncologic 18F-FDG PET/CT imaging.

Ryan D Niederkohr¹, Bennett S Greenspan, John O Prior

¹Department of Nuclear Medicine, Kaiser Permanente Medical Center, Santa Clara, CA, USA. ryan.d.niederkohr@kp.org

Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine

|April 12, 2013

Summary

High-quality PET/CT reports are crucial for patient care and legal documentation. This guide details essential elements for concise and complete oncologic (18)F-FDG PET/CT reports in clinical practice.

Keywords:

PET/CT oncology reporting

More Related Videos

A Practical Guide for the Production and PET/CT Imaging of 68Ga-DOTATATE for Neuroendocrine Tumors in Daily Clinical Practice

A Practical Guide for the Production and PET/CT Imaging of ⁶⁸Ga-DOTATATE for Neuroendocrine Tumors in Daily Clinical Practice

Published on: April 17, 2019

Related Experiment Videos

Last Updated: May 12, 2026

Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT

Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT

Published on: January 22, 2018

A Practical Guide for the Production and PET/CT Imaging of 68Ga-DOTATATE for Neuroendocrine Tumors in Daily Clinical Practice

A Practical Guide for the Production and PET/CT Imaging of ⁶⁸Ga-DOTATATE for Neuroendocrine Tumors in Daily Clinical Practice

Published on: April 17, 2019

Area of Science:

Radiology and Nuclear Medicine
Medical Communication

Background:

The physician's report is the primary communication tool between radiologists and referring physicians.
Accurate reporting influences patient management, clinical outcomes, and legal documentation.
PET/CT reports are complex due to the hybrid imaging modality.

Framework:

Essential elements for a concise and complete oncologic (18)F-FDG PET/CT report.
Structured reporting guidelines for clarity and completeness.
Standardized elements for improved diagnostic accuracy.

Implementation:

Illustrates essential elements with examples from clinical practice.
Focuses on practical application for generating high-quality reports.
Provides a template for oncologic (18)F-FDG PET/CT reporting.

Implications:

Enhances physician communication and patient care.
Ensures accurate medical necessity, billing, and regulatory compliance.
Improves the quality and consistency of oncologic imaging reports.